A detailed history of Silverberg Bernstein Capital Management LLC transactions in Pharming Group N.V. stock. As of the latest transaction made, Silverberg Bernstein Capital Management LLC holds 41,110 shares of PHAR stock, worth $309,558. This represents 0.31% of its overall portfolio holdings.

Number of Shares
41,110
Previous 23,435 75.42%
Holding current value
$309,558
Previous $196 Million 73.32%
% of portfolio
0.31%
Previous 0.19%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 04, 2024

BUY
$6.82 - $8.96 $120,543 - $158,368
17,675 Added 75.42%
41,110 $339 Million
Q2 2024

Jul 12, 2024

BUY
$7.27 - $11.3 $41,620 - $64,692
5,725 Added 32.33%
23,435 $196 Million
Q4 2023

Jan 17, 2024

BUY
$10.0 - $12.53 $177,100 - $221,906
17,710 New
17,710 $202 Million

Others Institutions Holding PHAR

About Pharming Group N.V.


  • Ticker PHAR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 65,241,400
  • Market Cap $491M
  • Description
  • Pharming Group N.V., a biopharmaceutical company, develops and commercialize protein replacement therapies and precision medicines for the treatment of rare diseases and unmet medical needs in the United States, Europe, and internationally. The company's lead product is Ruconest, a recombinant human C1 esterase inhibitor that is used for the tre...
More about PHAR
Track This Portfolio

Track Silverberg Bernstein Capital Management LLC Portfolio

Follow Silverberg Bernstein Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Silverberg Bernstein Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Silverberg Bernstein Capital Management LLC with notifications on news.